Asthmatic patients’ poor awareness of inadequate disease control: a pharmacy-based survey

Laforest, Laurent; Ganse, Éric Van; Devouassoux, Gilles; Osman, Liesl; Kitio, Brice; Massol, Jacques; Bauguil, G.; Chamba, G.

doi:10.1016/s1081-1206(10)60687-4

Cited by 43 publications

(36 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, 46% had at least one symptom and had used a bronchodilator at least once during the previous week. In France, a survey of .1,500 asthma patients found that 70% of patients were inadequately controlled and 69% failed to recognise their poor control, instead believing that they were completely or well controlled [53]. Breathlessness, use of rescue medication and impairment of daily activities were common.…”

Section: The Brussels Declaration On Asthma S Holgate Et Almentioning

confidence: 99%

The Brussels Declaration: the need for change in asthma management

et al. 2008

View full text Add to dashboard Cite

Asthma is a highly prevalent condition across Europe and numerous guidelines have been developed to optimise management. However, asthma can be neither cured nor prevented, treatment choices are limited and many patients have poorly controlled or uncontrolled asthma.The Brussels Declaration on Asthma, sponsored by The Asthma, Allergy and Inflammation Research Charity, was developed to call attention to the shortfalls in asthma management and to urge European policy makers to recognise that asthma is a public health problem that should be a political priority.The Declaration urges recognition and action on the following points: the systemic inflammatory component of asthma should be better understood and considered in assessments of treatment efficacy; current research must be communicated and responded to quickly; the European Medicines Agency guidance note on asthma should be updated; ''real world'' studies should be funded and results used to inform guidelines; variations in care across Europe should be addressed; people with asthma should participate in their own care; the impact of environmental factors should be understood; and targets should be set for improvement.The present paper reviews the evidence supporting the need for change in asthma management and summarises the ten key points contained in the Brussels Declaration.

show abstract

Section: The Brussels Declaration On Asthma S Holgate Et Almentioning

confidence: 99%

The Brussels Declaration: the need for change in asthma management

et al. 2008

View full text Add to dashboard Cite

show abstract

“…It has been demonstrated that community pharmacies are suitable venues to identify patients in need of asthma education, i.e. those with poorly-controlled asthma and those with poor medication adherence identifiable through pharmacy records [31,32].…”

Section: Introductionmentioning

confidence: 99%

Asthma disease management—Australian pharmacists’ interventions improve patients’ asthma knowledge and this is sustained

Saini

LeMay

Emmerton

et al. 2011

Patient Education and Counseling

View full text Add to dashboard Cite

Objectives: To assess any improvements in knowledge of asthma patients after a tailored education program delivered by pharmacists and measure the sustainability of any improvements. To ascertain patients' perceptions about any changes in their knowledge.Methods: 96 specially trained pharmacists recruited patients based on their risk of poor asthma control. A tailored intervention was delivered to patients based on individual needs and goals, and was conducted at three or four time points over six months. Asthma knowledge was assessed at the beginning and end of the service, and six and 12 months after it had ended. Patients' perceptions of the impact of the service on their knowledge were explored qualitatively in interviews.

show abstract

“…Although wheezing is one of the best discriminators of asthma (31), many of our participants did not perceive this symptom. A large pharmacy study also confirmed suboptimal symptom perception by tracking the usage of symptom-based rescue medications; however, there was no comparison of ethnic groups in that study (32). Important differences in the descriptors of asthma have been noted by Vincent et al, with patients and physicians using different words, such as "exacerbations" and "attacks" (33).…”

Section: Discussionmentioning

confidence: 78%

Differing Reports of Asthma Symptoms in African Americans and Caucasians

Trochtenberg¹,

BeLue

Piphus³

et al. 2008

Journal of Asthma

View full text Add to dashboard Cite

Objective-This pilot study explores the reported symptoms in African Americans and Caucasians with asthma.Methods-Asthma patients in an inner-city pulmonary clinic were given a brief questionnaire of asthma symptoms and the BORG scale, followed by spirometry.Results-African Americans were less likely to report nocturnal awakenings (67% vs. 100%; p = 0.037), complain of dyspnea (33% vs. 75%; p = 0.038), or experience chest pain (13% vs. 75%; p=0.002) than Caucasians.Conclusions-This is the first study to demonstrate that there are clinically significant differences in the reporting of asthma symptoms between African Americans and Caucasians.

show abstract

Asthmatic patients’ poor awareness of inadequate disease control: a pharmacy-based survey

Cited by 43 publications

References 22 publications

The Brussels Declaration: the need for change in asthma management

The Brussels Declaration: the need for change in asthma management

Asthma disease management—Australian pharmacists’ interventions improve patients’ asthma knowledge and this is sustained

Differing Reports of Asthma Symptoms in African Americans and Caucasians

Contact Info

Product

Resources

About